EDGAR Filing Documents for 0001193125-17-076937

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001193125-17-076937

Filing Date

2017-03-09

Accepted

2017-03-09 16:28:19

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	d236905ds3.htm	S-3	129972
2	EX-5.1	d236905dex51.htm	EX-5.1	10786
3	EX-23.1	d236905dex231.htm	EX-23.1	1356
4	GRAPHIC	g236905g23l92.jpg	GRAPHIC	2433
5	GRAPHIC	g236905g42s13.jpg	GRAPHIC	4467
6	GRAPHIC	g236905g48r45.jpg	GRAPHIC	1634
	Complete submission text file	0001193125-17-076937.txt		155288

Mailing Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080

Business Address 151 OYSTER POINT BLVD. SUITE 400 SOUTH SAN FRANCISCO CA 94080 650.515.3185

CytomX Therapeutics, Inc. (Filer) CIK: 0001501989 (see all company filings)

IRS No.: 273521219 | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-216567 | Film No.: 17678857
SIC: 2834 Pharmaceutical Preparations